WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post

The company joins Sinopharm as a Chinese supplier endorsed by the World Health Organization; the move has the potential to help WHO’s dose-strapped Covax vaccine distribution programme.This content was originally published here.

WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post

One Comment on “WHO approves Sinovac Biotech’s coronavirus vaccine for emergency use, the second Chinese treatment to win designation | South China Morning Post”

Leave a Reply